Literature DB >> 23117897

Analysis of cardiopulmonary coupling to assess adaptive servo-ventilation success in complex sleep apnea management.

Kannan Ramar1, Benoît Desrues, Priya Ramar, Timothy I Morgenthaler.   

Abstract

BACKGROUND: Adaptive servo-ventilation (ASV) is used to treat complex sleep apnea syndrome (CompSAS), but with variable success. Factors influencing success are poorly understood. ASV devices determine their output based upon characteristics of a given breath and on proprietary algorithms that assume a periodic breathing pattern. Periodic breathing patterns produce elevated narrow band low-frequency cardiopulmonary coupling (eNB-LFC). Therefore, we hypothesized that ASV success would correlate with elevated proportions of periodic breathing as marked by eNB-LFC on cardiopulmonary coupling (CPC) analysis.
METHODS: This was a retrospective study of 106 consecutive patients presenting to an academic tertiary care sleep center with CompSAS between July 2008 and July 2009 who underwent ASV titration with polysomnographic signals amenable to CPC analysis.
RESULTS: The study included 89 males (84 %) and 17 females (16 %), with mean age of 63.3 years. Median diagnostic apnea-hypopnea index (AHI) was 38 (21, 56)/h, and on continuous positive airway pressure (CPAP), the median residual AHI (CompSAS) was 36.5 (23, 58)/h, with central apneas occurring on average 22.5 (13, 39)/h. ASV brought AHI to 11.0 ± 13.0, with success in 81.1 % of patients, as defined by an AHI of <10/h. NB-LFC was elevated (>0) in 45.3 %; however, the percentage of eNB-LFC did not correlate with ASV treatment success (p = 0.518). No clinical factors were found to be associated with ASV success.
CONCLUSION: ASV was successful in 81 % of patients with CompSAS. However, eNB-LFC calculated from CPC, a marker for periodic breathing, did not correlate with ASV success and therefore may not be a useful tool to predict ASV success.

Entities:  

Mesh:

Year:  2012        PMID: 23117897     DOI: 10.1007/s11325-012-0780-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  22 in total

Review 1.  Respiratory modulation of heart rate and blood pressure during Cheyne-Stokes respiration.

Authors:  Richard S T Leung; T Douglas Bradley
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

2.  Comparison of two servo ventilator devices in the treatment of complex sleep apnea.

Authors:  Tomasz J Kuzniar; Smita Patel; Cynthia L Nierodzik; Loretta C Smith
Journal:  Sleep Med       Date:  2011-05-14       Impact factor: 3.492

3.  Sleep-disordered breathing in stable methadone programme patients: a pilot study.

Authors:  H Teichtahl; A Prodromidis; B Miller; G Cherry; I Kronborg
Journal:  Addiction       Date:  2001-03       Impact factor: 6.526

4.  Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure.

Authors:  H Teschler; J Döhring; Y M Wang; M Berthon-Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

5.  Complex sleep apnoea in congestive heart failure.

Authors:  Thomas Bitter; Nina Westerheide; Mohammed Sajid Hossain; Roman Lehmann; Christian Prinz; Astrid Kleemeyer; Dieter Horstkotte; Olaf Oldenburg
Journal:  Thorax       Date:  2011-03-10       Impact factor: 9.139

6.  Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.

Authors:  Kannan Ramar; Priya Ramar; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

7.  Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration.

Authors:  Takatoshi Kasai; Yasuhiro Usui; Toru Yoshioka; Naotake Yanagisawa; Yoshifumi Takata; Koji Narui; Tetsu Yamaguchi; Akira Yamashina; Shin-ich Momomura
Journal:  Circ Heart Fail       Date:  2009-11-20       Impact factor: 8.790

8.  A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure.

Authors:  Justin C T Pepperell; Nick A Maskell; David R Jones; Beverley A Langford-Wiley; Nicky Crosthwaite; John R Stradling; Robert J O Davies
Journal:  Am J Respir Crit Care Med       Date:  2003-08-19       Impact factor: 21.405

9.  Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration.

Authors:  Winfried J Randerath; Wolfgang Galetke; Sven Stieglitz; Cordula Laumanns; Thorsten Schäfer
Journal:  Sleep Med       Date:  2008-07-21       Impact factor: 3.492

10.  Differentiating obstructive from central and complex sleep apnea using an automated electrocardiogram-based method.

Authors:  Robert Joseph Thomas; Joseph E Mietus; Chung-Kang Peng; Geoffrey Gilmartin; Robert W Daly; Ary L Goldberger; Daniel J Gottlieb
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

View more
  4 in total

1.  Electrocardiogram-based sleep analysis for sleep apnea screening and diagnosis.

Authors:  Yan Ma; Shuchen Sun; Ming Zhang; Dan Guo; Arron Runzhou Liu; Yulin Wei; Chung-Kang Peng
Journal:  Sleep Breath       Date:  2019-06-21       Impact factor: 2.816

Review 2.  Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches.

Authors:  Andrey V Zinchuk; Mark J Gentry; John Concato; Henry K Yaggi
Journal:  Sleep Med Rev       Date:  2016-10-12       Impact factor: 11.609

3.  An electrocardiogram-based analysis evaluating sleep quality in patients with obstructive sleep apnea.

Authors:  John Harrington; Preetam J Schramm; Charles R Davies; Teofilo L Lee-Chiong
Journal:  Sleep Breath       Date:  2013-01-25       Impact factor: 2.816

4.  Cardiopulmonary coupling analysis: changes before and after treatment with a mandibular advancement device.

Authors:  Woo Hyun Lee; Jae-Cheul Ahn; Jaewoon We; Chae-Seo Rhee; Chul Hee Lee; Pil-Young Yun; In-Young Yoon; Jeong-Whun Kim
Journal:  Sleep Breath       Date:  2014-04-04       Impact factor: 2.816

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.